MedTrace Logo

Testosterone for Peripheral Vascular Disease

NCT00504712 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2022-06-08

Study results available
· View outcomes & findings →

Summary

There is increasing evidence of the linkage of type 2 diabetes with low testosterone levels in men.

Conditions

Interventions

DRUG

Testosterone

Sustanon- 200mg- Intramuscular testosterone every 2 weeks

DRUG

saline

Saline injection every two weeks

Sponsors & Collaborators

  • Barnsley Hospital

    lead OTHER

Principal Investigators

  • Thomas H Jones · Barnsley Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-02-28
Primary Completion
2009-12-31
Completion
2009-12-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00504712 on ClinicalTrials.gov